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MDA helminth control: more questions than answers
Soil-transmitted helminths (STH) and schistosomiasis 
have been recognised as important diseases. Diagnostics, 
treatments, and understanding of these were accrued 
throughout the 20th century, and reached the point 
that control and elimination seemed to be mostly a 
matter of implementation of mass drug administration 
(MDA) programmes.1 However, in 2015, both STH and 
schistosomiasis are global health problems, so perhaps 
we do not have the right methods or they are not being 
eﬀ ectively applied. To our knowledge, MDA for STH and 
schistosomiasis has never been reported to eliminate 
infection without concomitant economic development. 
What are we missing?
Most understanding about infection and disease is 
from longitudinal intervention studies completed in 
the 1980s and 1990s,2–5 which are now ageing and 
rarely beneﬁ ted from modern techniques, such as next-
generation sequencing. Very surprising is how much is 
not fully understood about these infections—eg, the 
biological or ecological basis of predisposition to high 
worm burdens, the importance of household-based 
transmission, the causes and resulting eﬀ ects of co-
infection with many parasites, and how to measure the 
burden of disease.
Measurement of the burden of disease is particularly 
vexing. Cochrane reviews, published in 20126 and 
20157, have emphasised the paucity of information 
(only 42 and 45 papers were included, respectively) 
and reported that little evidence was available for any 
beneﬁ cial eﬀ ect of deworming, even though people 
in the ﬁ eld were convinced that these result in a great 
eﬀ ect on physical and mental health.8 By contrast, 
evidence of the eﬀ ects in livestock and wildlife is 
accruing.9 More than 1 billion children worldwide live at 
risk of helminth infection,10 and yet the eﬀ ect on their 
health and development still cannot be quantiﬁ ed.
In The Lancet Global Health, Nathan Lo and colleagues11 
introduce two advances that should be highlighted. 
First is the inclusion of ﬁ ve diﬀ erent parasites in the 
same study, which is sensible, in view of the substantial 
overlap in diagnostic procedures and treatments for 
the diﬀ erent species. Second, the authors11 worked with 
detailed data in one setting (Côte d’Ivoire) and made 
comparisons between diﬀ erent communities within 
that setting; such linkage between consistent local data 
and models is rare. Helminth infection and disease can 
be very diﬀ erent in diﬀ erent communities, but well 
validated models in many settings might allow for the 
extrapolation to others. We would like to think that this 
paper11 marks the demise for universal studies of single 
helminth species.
Lo and colleagues11 also add to the evidence that 
MDA might need to be widened beyond school-aged 
children (5–14 years). Diﬀ erent frequencies of treatment 
are known to be needed for communities with 
diﬀ erent intensities of infection, but less appreciated 
is that diﬀ erent age groups need to be treated for 
diﬀ erent circumstances, particularly with the aim to 
stop transmission of infections.12 Lo and colleagues’ 
results11 suggest that widening coverage to additional 
age groups could be highly cost eﬀ ective in terms of 
disability-adjusted life-years averted, motivating wider 
treatment programmes for eﬀ ect rather than purely for 
the aim of local elimination.
Generally, we need interventions that are sustainable 
in the face of social, economic, and ecological 
heterogeneities. Models need to guide intervention 
programmes in terms of what to measure and how 
to use this information to manage the intervention. 
However, this task is diﬃ  cult for modellers to provide 
because detailed data from many settings do not exist; 
or in settings where data do exist, the mechanisms 
to share these are not available in a way that provides 
useful results for both individual countries and wider 
policy formulation.
Lo and colleagues’ study11 emphasises the need 
for additional longitudinal studies of infection and 
disease—with longer follow-up time than have been 
done previously, especially if the negative sequelae of 
infection in children starts while they are very young and 
lasts for decades. Such future studies need a broadening 
of research approaches, particularly to include 
multiparasitism, the concepts of parasite tolerance (ie, 
that some individuals can harbour high burdens with 
relatively little eﬀ ect on their health), social dimensions 
(ie, people with the highest burdens are less likely 
to be included in interventions and research studies, 
possibly because of their high burden, than those with 
low burdens), and potential reservoirs of transmission 
(ie, the role of households and environmental 
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contamination). Confounders and mediators (eg, 
nutrition, poverty, and microbiota) also need to be 
taken into account.
Of course, it should be emphasised that whether 
MDA can eliminate transmission, or whether it will 
ultimately need improvement in the quality of the water 
supply, sanitation, and hygiene, is yet to be shown. 
Nonetheless, MDA is the mainstay of control for the 
present generations, and we need to know whether, and 
how, we should use this method.
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